Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 854 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed619    
    Printed31    
    Emailed0    
    PDF Downloaded54    
    Comments [Add]    

Recommend this journal

 
ARTICLE
Year : 1991  |  Volume : 33  |  Issue : 2  |  Page : 104-107

A Double-Blind Evaluation of Alprazolam and Imipramine in the Treatment of Major Depression


1 Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bangalore 560029, India
2 Department of Psychiatry, K. E.M. Hospital and Seth G. S. Medical College, Mumbai 400012, India
3 Department of Psychiatry, G. B. Pant Hospital, Maulana Azad Medical College, New Delhi-110002, India
4 Department of Psychiatry, Madras Medical College and Government General Hospital, Madras-600001, India
5 Department of Psychiatry, Upjohn International Inc., India Liaison Office, New Delhi, India

Correspondence Address:
R S Murthy
Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bangalore 560029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 21897464

Rights and PermissionsRights and Permissions

This report describes the results of a multicentre collaborative study comparing the safety and efficacy of alprazolam with imipramine in patients suffering from major depressive disorder. Two hundred and eight patients diagnosed as major depression as per DSM-III criteria were randomly allocated to alprazolam (N= 105) or imipramine (N = 103) in a double-blind fashion. Detailed assessments were carried out for a period of six weeks. Results revealed that alprazolam was as effective as imipramine as an antidepressant. Side effects were less frequently reported with alprazolam.



[PDF]*

        

Print this article         Email this article